ONCY
Price:
$0.958
Market Cap:
$100.07M
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgar...[Read more]
Industry
Biotechnology
IPO Date
2001-10-05
Stock Exchange
NASDAQ
Ticker
ONCY
According to Oncolytics Biotech Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.99. This represents a change of -25.12% compared to the average of 6.67 of the last 4 quarters.
The mean historical Current Ratio of Oncolytics Biotech Inc. over the last ten years is 7.56. The current 4.99 Current Ratio has changed 6.50% with respect to the historical average. Over the past ten years (40 quarters), ONCY's Current Ratio was at its highest in in the March 2021 quarter at 22.15. The Current Ratio was at its lowest in in the December 2019 quarter at 1.47.
Average
7.56
Median
7.07
Minimum
1.47
Maximum
16.69
Discovering the peaks and valleys of Oncolytics Biotech Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 746.56%
Maximum Annual Current Ratio = 16.69
Minimum Annual Increase = -71.35%
Minimum Annual Current Ratio = 1.47
Year | Current Ratio | Change |
---|---|---|
2023 | 9.01 | -0.40% |
2022 | 9.05 | -45.82% |
2021 | 16.69 | 34.06% |
2020 | 12.45 | 746.56% |
2019 | 1.47 | -71.35% |
2018 | 5.13 | 50.72% |
2017 | 3.41 | -3.99% |
2016 | 3.55 | -64.29% |
2015 | 9.94 | 101.15% |
2014 | 4.94 | 7.20% |
The current Current Ratio of Oncolytics Biotech Inc. (ONCY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.58
5-year avg
9.73
10-year avg
7.56
Oncolytics Biotech Inc.’s Current Ratio is greater than scPharmaceuticals Inc. (4.84), less than Milestone Pharmaceuticals Inc. (19.13), greater than Seres Therapeutics, Inc. (1.38), less than aTyr Pharma, Inc. (6.07), less than DiaMedica Therapeutics Inc. (17.82), greater than Inhibikase Therapeutics, Inc. (2.32), less than X4 Pharmaceuticals, Inc. (0), less than Galera Therapeutics, Inc. (6.07), less than Terns Pharmaceuticals, Inc. (5.63), less than Day One Biopharmaceuticals, Inc. (21.02), greater than HOOKIPA Pharma Inc. (4.09), greater than CureVac N.V. (3.86), greater than Reata Pharmaceuticals, Inc. (2.29), greater than Krystal Biotech, Inc. (3.21), less than Vir Biotechnology, Inc. (9.50), less than Propanc Biopharma, Inc. (12.51), greater than null (0.00),
Company | Current Ratio | Market cap |
---|---|---|
4.84 | $255.65M | |
19.13 | $77.77M | |
1.38 | $145.36M | |
6.07 | $131.12M | |
17.82 | $172.27M | |
2.32 | $10.00M | |
0 | $109.78M | |
6.07 | $4.08M | |
5.63 | $549.60M | |
21.02 | $1.25B | |
4.09 | $159.50M | |
3.86 | $614.60M | |
2.29 | $6.57B | |
3.21 | $5.29B | |
9.50 | $1.06B | |
12.51 | $278.87K | |
0.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolytics Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncolytics Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Oncolytics Biotech Inc.'s Current Ratio?
How is the Current Ratio calculated for Oncolytics Biotech Inc. (ONCY)?
What is the highest Current Ratio for Oncolytics Biotech Inc. (ONCY)?
What is the 3-year average Current Ratio for Oncolytics Biotech Inc. (ONCY)?
What is the 5-year average Current Ratio for Oncolytics Biotech Inc. (ONCY)?
How does the current Current Ratio for Oncolytics Biotech Inc. (ONCY) compare to its historical average?